- Previous Close
0.290 - Open
0.320 - Bid 0.345 x --
- Ask 0.385 x --
- Day's Range
0.320 - 0.460 - 52 Week Range
0.094 - 1.270 - Volume
326,900 - Avg. Volume
28,094 - Market Cap (intraday)
109.531M - Beta (5Y Monthly) 1.16
- PE Ratio (TTM)
6.00 - EPS (TTM)
0.060 - Earnings Date Mar 28, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date Sep 24, 2002
- 1y Target Est
--
China Regenerative Medicine International Limited, an investment holding company, engages in the provision of healthcare products and services in Hong Kong and the People's Republic of China. It operates through Aesthetic Medical and Beauty Services; and Medical Services segments. The company offers medical beauty products and services; and medical products and services. The company was formerly known as China Bio-Med Regeneration Technology Limited and changed its name to China Regenerative Medicine International Limited in March 2015. China Regenerative Medicine International Limited was founded in 1995 and is headquartered in Tsim Sha Tsui, Hong Kong.
www.crmi.hkRecent News: 8158.HK
View More
Performance Overview: 8158.HK
Trailing total returns as of 4/14/2025, which may include dividends or other distributions. Benchmark is HANG SENG INDEX (^HSI) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 8158.HK
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 8158.HK
View MoreValuation Measures
Market Cap
88.23M
Enterprise Value
119.22M
Trailing P/E
4.97
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.97
Price/Book (mrq)
3.50
Enterprise Value/Revenue
1.32
Enterprise Value/EBITDA
6.31
Financial Highlights
Profitability and Income Statement
Profit Margin
19.59%
Return on Assets (ttm)
2.38%
Return on Equity (ttm)
95.98%
Revenue (ttm)
90.62M
Net Income Avi to Common (ttm)
17.75M
Diluted EPS (ttm)
0.060
Balance Sheet and Cash Flow
Total Cash (mrq)
57.45M
Total Debt/Equity (mrq)
213.08%
Levered Free Cash Flow (ttm)
--